Remicade (infliximab) 4 DMARDs for rheumatoid arthritis infusion therapy Rituxan (rituximab) It belongs to a class of biologics that targets specialized immune cells known as B cells. In RA, B cells produce auto-antibodies that target and damage healthy cells and tissues. Rituxan acts by prevent...
Biologics are medicines made from living cells. They belong to a class of drugs called disease-modifying antirheumatic drugs (DMARDs). They treat rheumatoid arthritis (RA) by targeting specific molecules involved in the inflammation process.
Graft versus host disease, or GVHD, is a complication of a stem cell transplant, a treatment for blood cancers and certain blood or immune system disorders. With GVHD, white blood cells called T cells from the donor -- the graft, or the “G” in GVHD -- attack cells within the recipie...
Biologics are a new class of drugs that are protein-based and synthesized by living cells. Biologics are given by injection or intravenous (IV) infusion and rather than affecting the entire immune system, they target specific parts of the immune system that cause the psoriasis symptoms. These t...
helps lessen inflammation. Not only do these drugs help manage pain, but they can reduce further joint damage, as they aim to stop the disease’s progression and rebalance the immune system. This class of drugs can be nonbiologic, like methotrexate, or biologic, like Humira or Remicade. ...